Wellington Management Group
ARTV

Wellington Management Group’s Artiva Biotherapeutics ARTV Stock Holding History

Wellington Management Group’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Hold
194,108
– – ﹤0.01% 1636
2025
Q4 		$833K Hold
194,108
– – ﹤0.01% 1749
2025
Q3 		$557K Hold
194,108
– – ﹤0.01% 1871
2025
Q2 		$293K Hold
194,108
– – ﹤0.01% 1881
2025
Q1 		$582K Hold
194,108
– – ﹤0.01% 1802
2024
Q4 		$1.95M Hold
194,108
– – ﹤0.01% 1570
2024
Q3 		$2.91M Buy
+194,108
New +$2.25M ﹤0.01% 1453

Other funds holding ARTV

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wellington Management Group's ARTV Position: Q1 2026 in Review

Wellington Management Group held its Artiva Biotherapeutics (ARTV) position steady in Q1 2026 at 194,108 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Wellington Management Group first reported a position in ARTV in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.91M in Q3 2024. 40 funds tracked by Wall St. Rank hold ARTV as of Q1 2026.

  • Wellington Management Group held 194,108 shares of Artiva Biotherapeutics worth $1.25M as of Q1 2026.
  • Wellington Management Group left its Artiva Biotherapeutics share count unchanged in Q1 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1636 holding.
  • Wellington Management Group first reported a position in Artiva Biotherapeutics in Q3 2024 and has held it in 7 quarters since.
  • Wellington Management Group's Artiva Biotherapeutics position peaked at $2.91M in Q3 2024.
  • 40 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.